James Healy

Board Member · Natera, Inc.

Rank #277 SEC EDGAR (United States) ↗ Files from United States

Details

Member of the boardHealthcare Providers & ServicesNTRASEC CIK 0001245624

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$637.4M
1-day change
▼ 0.43%
Positions on file
3
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 3 currently disclosed positions would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$307.9M – $648.2M2026-09-04

Insider activity Apr 26, 2024 – Sep 16, 2025

James Healy is recorded in filings to the U.S. SEC via EDGAR as member of the board, and reported 35 transactions between Apr 26, 2024 and Sep 16, 2025. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
$22.58M
22 purchases on file priced rows only
Open-market sales (code S)
None
0 sales on file
All reported transactions
35
every code, including awards and exercises
Pattern
Bought and sold in similar amounts
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

James Healy bought 588,888 BioAge Labs, Inc. (BIOA) shares for $10,599,984 on Sep 27, 2024

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

James Healy bought 588,888 BioAge Labs, Inc. (BIOA) shares for $10,599,984 on Sep 27, 2024
Date Insider Transaction Shares Price Value Filing
Sep 27, 2024 James Healy P Open-market purchase 588,888 held after: 2,227,124 $18.00 $10,599,984 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 25 most recent rows are grouped into 9 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 32 on file in total. See the full history on EDGAR ↗

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Seaport Therapeutics, Inc. SPTX C Conversion of derivative × 2not a buy/sell decisionreported at zero 2,731,538 shares $0
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    804,379 $0.00reported at zero $0 SEC filing ↗
    1,927,159 $0.00reported at zero $0 SEC filing ↗
  2. Natera, Inc. NTRA A Grant or awardnot a buy/sell decisionreported at zero 142 shares $0 at $0.00 SEC filing ↗
  3. Natera, Inc. NTRA A Grant or awardnot a buy/sell decisionreported at zero 114 shares $0 at $0.00 SEC filing ↗
  4. Natera, Inc. NTRA A Grant or awardnot a buy/sell decisionreported at zero 153 shares $0 at $0.00 SEC filing ↗
  5. BioAge Labs, Inc. BIOA P Open-market purchase × 5 666,665 shares $12.00M
    The 5 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    11,113 $18.00 $200.0K SEC filing ↗
    21,814 $18.00 $392.7K SEC filing ↗
    18,353 $18.00 $330.4K SEC filing ↗
    26,497 $18.00 $476.9K SEC filing ↗
    588,888 $18.00 $10.60M SEC filing ↗
  6. BioAge Labs, Inc. BIOA C Conversion of derivativenot a buy/sell decisionreported at zero 1,638,236 shares $0 at $0.00 SEC filing ↗
  7. Natera, Inc. NTRA A Grant or awardnot a buy/sell decisionreported at zero 177 shares $0 at $0.00 SEC filing ↗
  8. Rapport Therapeutics, Inc. RAPP P Open-market purchase × 12 44,032 shares $1.08M
    The 12 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    3,657 $24.21 $88.5K SEC filing ↗
    3,630 $23.08 $83.8K SEC filing ↗
    2,748 $26.06 $71.6K SEC filing ↗
    4,878 $25.02 $122.0K SEC filing ↗
    3,828 $24.21 $92.7K SEC filing ↗
    3,799 $23.08 $87.7K SEC filing ↗
    2,559 $26.06 $66.7K SEC filing ↗
    4,544 $25.02 $113.7K SEC filing ↗
    3,565 $24.21 $86.3K SEC filing ↗
    3,538 $23.08 $81.7K SEC filing ↗
    2,625 $26.06 $68.4K SEC filing ↗
    4,661 $25.02 $116.6K SEC filing ↗
  9. Natera, Inc. NTRA A Grant or awardnot a buy/sell decisionreported at zero 2,964 shares $0 at $0.00 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
Natera, Inc. NTRA Common Stock (indirect) 1,596,540 $328.18 $524.0M 4 EDGAR ↗
Rapport Therapeutics, Inc. RAPP Common Stock (indirect) 1,995,594 $45.77 $91.3M 4 EDGAR ↗
BioAge Labs, Inc. BIOA Common Stock (indirect) 2,304,901 $9.59 $22.1M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where James Healy reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.